<p>The present invention refers to antibodies, particularly to monoclonal antibodies, which bind to the extracellular domain of the AXL receptor tyrosine kinase and which at least partially inhibit AXL activity.</p>
申请公布号
SG10201405835T(A)
申请公布日期
2014.10.30
申请号
SGT10201405835
申请日期
2008.11.12
申请人
U3 PHARMA GMBH
发明人
HETTMANN, THORE;NIEWÖHNER, JENS;RUHE, JENS;WIRTZ, PETER;SELLE, KERSTIN;ZWICK-WALLASCH, ESTHER;ROTHE, MIKE
